(Q41644116)

6 October 2017

1 reference

title

Vaccine design, evaluation, and community-based use for antigenically variable infectious agents (English)

1 reference

6 October 2017

1 reference

2

1 reference

6 October 2017

R M Anderson

1

1 reference

6 October 2017

S Gupta

series ordinal

3

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

350

1 reference

6 October 2017

issue

9089

1 reference

6 October 2017

page(s)

1466-1470

1 reference

Implications of genetic variability in HIV for epidemiology and public health

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Recombination in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Antigenic variation and the within-host dynamics of parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Antigenic Diversity Thresholds and the Development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

The estimation of age-related rates of infection from case notifications and serological data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Impact of vaccination on the spatial correlation and persistence of measles dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Pulse mass measles vaccination across age cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Mass vaccination to control chickenpox: the influence of zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Low-efficacy HIV vaccines: potential for community-based intervention programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Re: "The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Evaluation of mumps vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Immunisation and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Chaos and complexity in measles models: a comparative numerical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Space, persistence and dynamics of measles epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Dynamical complexity in age-structured models of the transmission of the measles virus: epidemiological implications at high levels of vaccine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Disease extinction and community size: modeling the persistence of measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Assessing HIV vaccine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Study designs for dependent happenings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

The maintenance of strain structure in populations of recombining infectious agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Antigenic diversity and the transmission dynamics of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

The Croonian Lecture, 1994. Populations, infectious disease and immunity: a very nonlinear world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Pneumococcal virulence factors and host immune responses to them

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Vaccination against colonizing bacteria with multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Vaccination and the population structure of antigenically diverse pathogens that exchange genetic material

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

Molecular virology and pathogenesis of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

The next pandemic influenza virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903255-8

7 January 2021

10.1016/S0140-6736(97)03255-8

Identifiers

DOI

1 reference

6 October 2017

1 reference